
Insurance reversal clears DBS path for teen with treatment-resistant epilepsy
A 13-year-old with drug-resistant epilepsy faced a denial for deep brain stimulation because it wasn’t FDA-approved for children; after NBC News coverage, Anthem Blue Cross Blue Shield approved DBS and later updated its policy to cover pediatric DBS for epilepsy, offering new hope for reducing seizure frequency and improving quality of life.













